Bumetanide
- Product NDC
- 0832-0542
- 11-digit product format
- 008320542
- Labeler code
- 0832
- Product ID
- 0832-0542_d53166d9-64ca-4b76-81a7-b70a60c53b12
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BUMETANIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Upsher-Smith Laboratories, LLC
- Application
- ANDA209916
- Marketing category
- ANDA
- Marketing start
- 2018-01-30
- Marketing end
- 2026-09-30
- Substance
- BUMETANIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bumetanide
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BUMETANIDE | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0Y2S3XUQ5H |
| Rxcui | 197417, 197418, 197419 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0832-0542-10 | Bumetanide | 1000 in 1 BOTTLE | TABLET | 1000 | | 7 |
| 0832-0542-11 | Bumetanide | 100 in 1 BOTTLE | TABLET | 100 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0832-0542 | BUMETANIDE TABLET [UPSHER-SMITH LABORATORIES, LLC] | 6 | Current NDC, Legacy NDC, 2 package rows | 20240301_ff5dc8c6-b2f2-41d3-8e56-a953aa721b59.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0832-0542-10 | 00832054210 | 1000 TABLET in 1 BOTTLE (0832-0542-10) | 1000 tablet | 2018-01-30 | 2026-09-30 | No | No | Current |
| 0832-0542-11 | 00832054211 | 100 TABLET in 1 BOTTLE (0832-0542-11) | 100 tablet | 2018-01-30 | 2026-09-30 | No | No | Current |